University of California, Irvine
600
96
138
312
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.2%
109 terminated/withdrawn out of 600 trials
74.1%
-12.4% vs industry average
7%
42 trials in Phase 3/4
43%
134 of 312 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (600)
Treatment of Tinnitus With Migraine Medications
Role: lead
Strategies for Pregnancy Achievement
Role: collaborator
Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma
Role: lead
Latinx Children and Surgery
Role: lead
Scientific Information and Beliefs About Psychological Therapy
Role: lead
Youth Nominated Support Team
Role: lead
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
Role: lead
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
Role: lead
Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
Role: collaborator
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
Role: lead
Treatment of Meniere's Disease With Migraine Medications
Role: lead
Digital CBT for Insomnia and Depression
Role: collaborator
Family Relationship Help
Role: lead
Optical Sensor for Photodynamic Detection of Oral Pathology
Role: lead
Acupressure in Patients With Sickle Cell Disease
Role: collaborator
Positive Affect Treatment for Adolescents With Early Life Adversity
Role: lead
Mapping Ibogaine Neural Dynamics in Opioid Use Disorder
Role: lead
Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)
Role: lead
My Life and My Experiences Project
Role: lead
Empiric Calcium in Massive Transfusion
Role: lead